Archives

by in
Entry Author Date Location
Cardiac Dimensions Wins EU Approval for Heart Failure Device, Aims for Market in 2012 09/29/11 Seattle
Valeritas Raises $150M for Insulin Device 09/13/11 New York
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sciences Secures $10,600,000 Series B Round 09/08/11 Seattle
BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News 07/20/11 Boston
Nevro Raises $58M for Anti-Pain Device 07/20/11 San Francisco
Nevro Lands $58,000,000 New Financing 07/20/11 San Francisco
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News 07/15/11 Boston
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors 07/14/11 Boston
Verastem Obtains $32,000,000 Series B Financing Round 07/14/11 Boston
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO 07/13/11 Seattle
Termeer Joins Verastem Board 06/13/11 Boston
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing 05/24/11 Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma 05/24/11 San Francisco
Radius Health Obtains $91,000,000 New Funding 05/24/11 Boston
Pacira Raises Wall Street Expectations of a New Blockbuster Painkiller 05/19/11 New York
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives 05/13/11 San Francisco
BayBio’s Annual Conference, Tweet by Tweet 04/22/11 San Francisco
Zacharon Aligns with Pfizer, Conatus Raises Big Bucks, Software Veteran Wins Wireless Institute Challenge, & More San Diego Life Sciences News 04/14/11 San Diego
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference 04/14/11 Boston
Conatus Adds $7.5M, Closes Series B Round 04/13/11 San Diego
Conatus Pharmaceuticals Secures $7,500,000 Series B Financing 04/13/11 San Diego
Genzyme-Spinout Peptimmune Files for Chapter 7 Liquidation 03/23/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
Allozyne Passes First Clinical Trial, Dreams Big About a Once-Monthly Multiple Sclerosis Drug 01/10/11 Seattle
23andMe Adds $9M to VC Round 01/07/11 San Francisco
23andMe Secures $9,000,000 Series C Financing Round 01/07/11 San Francisco
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients 12/10/10 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Page 2 of 7 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.